Menu
Search
Home > Courses > HCV and HIV in Persons Who Inject Drugs

HCV and HIV in Persons Who Inject Drugs

HCV and HIV in Persons Who Inject Drugs
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Approval Date: 9/17/2019
Published Date: 12/2/2019
Presenter
  • Brianna Norton, DO, MPH
    Associate Professor
    Albert Einstein College of Medicine
Presenter Bio
Brianna Norton, DO, MPH

Brianna Norton, DO, MPH is an assistant professor of medicine in the Divisions of General Internal Medicine and Infectious Diseases at Albert Einstein College of Medicine/ Montefiore Medical Center. Her clinical work includes the treatment of HCV, HIV, and opioid dependence in the primary care setting. She conducts research to improve linkage to HCV care and treatment for people who inject drugs. She is also the medical director of the NY Harm Reduction Educators, a syringe exchange program in East Harlem and the South Bronx.

Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

This CME activity was approved for AMA PRA Category 1 Credit on September 17, 2019 and will terminate September 16, 2022.


The target audience is all physicians, NPs and PAs involved or interested in HIV education.


This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.


The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Brianna Norton, DO (Presenter) had no relevant financial relationships to disclose. Dr. Norton submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules